IRIS
PANICHELLA, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.057
AS - Asia 3.702
EU - Europa 3.495
SA - Sud America 749
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 78
OC - Oceania 8
Totale 12.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.783
IT - Italia 1.472
SG - Singapore 1.327
CN - Cina 934
RU - Federazione Russa 855
BR - Brasile 584
VN - Vietnam 444
BD - Bangladesh 330
HK - Hong Kong 214
NL - Olanda 165
GB - Regno Unito 160
IE - Irlanda 158
DE - Germania 157
CA - Canada 154
FR - Francia 115
FI - Finlandia 107
IN - India 87
TR - Turchia 74
SE - Svezia 66
PL - Polonia 64
MX - Messico 63
AR - Argentina 61
PK - Pakistan 44
ES - Italia 36
ID - Indonesia 36
IQ - Iraq 36
EC - Ecuador 34
ZA - Sudafrica 32
IL - Israele 31
JP - Giappone 30
AT - Austria 26
CO - Colombia 25
UZ - Uzbekistan 21
UA - Ucraina 20
MA - Marocco 16
CH - Svizzera 15
EG - Egitto 13
LT - Lituania 13
BE - Belgio 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
VE - Venezuela 11
PH - Filippine 10
SA - Arabia Saudita 10
RO - Romania 9
HN - Honduras 8
KE - Kenya 8
MY - Malesia 8
PT - Portogallo 8
PY - Paraguay 8
PE - Perù 7
TN - Tunisia 7
AU - Australia 6
CR - Costa Rica 6
GT - Guatemala 6
JM - Giamaica 6
NP - Nepal 6
DZ - Algeria 5
JO - Giordania 5
KR - Corea 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
DK - Danimarca 4
GR - Grecia 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CG - Congo 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
GD - Grenada 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AG - Antigua e Barbuda 1
BH - Bahrain 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
Totale 12.080
Salva come PNG Salva come JPEG
Città #
Dallas 806
Singapore 724
San Jose 430
Ashburn 408
Beijing 325
Hong Kong 192
Council Bluffs 190
Los Angeles 164
Moscow 157
Dublin 155
Milan 154
Ho Chi Minh City 147
New York 125
Rome 105
Hanoi 101
Santa Clara 89
Helsinki 73
Pisa 65
São Paulo 63
Chandler 60
The Dalles 59
Florence 57
Lauterbourg 54
Warsaw 54
Hefei 53
Munich 49
Phoenix 46
Istanbul 45
Montreal 45
Naples 42
Orem 40
Amsterdam 36
Bologna 36
London 36
Boardman 35
Buffalo 34
Da Nang 34
Frankfurt am Main 34
Mexico City 34
Turin 33
Chicago 32
Beauharnois 29
Atlanta 28
Brooklyn 27
Tokyo 27
Genoa 26
Lucca 26
Rio de Janeiro 26
Toronto 26
Boston 24
Lappeenranta 24
Nuremberg 24
Poplar 24
Stockholm 24
Tel Aviv 23
Chennai 22
Denver 21
Johannesburg 21
Seattle 21
Brescia 20
Livorno 20
Figino 18
Houston 18
Tashkent 17
Palermo 16
Belo Horizonte 15
Hyde Park 15
Lahore 15
Manchester 15
Washington 15
Haiphong 14
Mumbai 14
Guayaquil 13
Quito 13
Shenzhen 13
Verona 13
Assago 12
Charlotte 12
Curitiba 12
Paris 12
Biên Hòa 11
Querétaro 11
Redondo Beach 11
Baghdad 10
Bari 10
Cagliari 10
Cambridge 10
Columbus 10
Dhaka 10
Ottawa 10
San Mateo 10
Vienna 10
Brasília 9
Kochi 9
Portsmouth 9
Suzhou 9
Turku 9
Zhengzhou 9
Ankara 8
Bergamo 8
Totale 6.369
Salva come PNG Salva come JPEG
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 633
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 470
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 346
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 337
Eligibility for vericiguat in a real‐world, contemporary heart failure population 311
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 305
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 297
Screening the health status of people working in a university 297
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 297
RNA-targeting and gene editing therapies for transthyretin amyloidosis 289
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 281
Assessing cardiac mechanics through left ventricular haemodynamic forces 252
Role of Imaging in Cardiomyopathies 246
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 245
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 245
Valvular heart disease in patients with cardiac amyloidosis 240
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 233
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 222
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 221
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 219
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 217
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 217
Cardiac Amyloidosis: How Its Epidemiology is Changing 216
Bridging Atrial and Ventricular Failure Through Biomarkers 213
Subclinical cardiac damage in cancer patients before chemotherapy 211
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population 209
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 206
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 205
Sex-related differences in ventricular remodeling after myocardial infarction 205
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis 201
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 190
Sex differences in transthyretin cardiac amyloidosis 189
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 186
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 185
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity 184
Pathophysiology of Cardiac Amyloidosis 183
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 183
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 182
Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review 181
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 171
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 168
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat 165
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 163
CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis 162
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 147
Dissecting the heart failure phenotype through phenomics 147
Metabolomics to predict heart failure development: A new frontier? 144
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift 128
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 127
Pirfenidone as a novel cardiac protective treatment 126
Insulin‐like growth factor binding protein‐7 in heart failure: The challenge of moving from risk prediction to a biomarker‐guided management 122
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 122
Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow‐up 119
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 118
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 80
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 56
The evolving role of metabolic and bariatric surgery in contemporary clinical practice 46
PAWP vs LVEDP During Invasive Cardiopulmonary Exercise Testing: In Search of the Holy Grail of a Hemodynamic Truth in Heart Failure. 38
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 33
Therapy of amyloidosis: stabilizers and silencers 25
Event rates in major Phase 3 heart failure trials over the last 20 years 25
Totale 12.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202266 0 0 0 5 7 7 10 17 7 6 2 5
2022/2023367 5 28 10 21 44 40 14 47 109 10 27 12
2023/2024333 13 11 63 36 7 25 27 13 15 26 28 69
2024/20252.734 71 68 134 108 184 154 383 539 286 145 358 304
2025/20267.971 421 1.059 740 1.119 785 547 737 453 520 533 568 489
2026/2027710 256 257 197 0 0 0 0 0 0 0 0 0
Totale 12.181